Cystic Fibrosis and Oxidative Stress: The Role of CFTR.


Journal

Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009

Informations de publication

Date de publication:
21 Aug 2022
Historique:
received: 27 07 2022
revised: 18 08 2022
accepted: 19 08 2022
entrez: 26 8 2022
pubmed: 27 8 2022
medline: 30 8 2022
Statut: epublish

Résumé

There is substantial evidence in the literature that patients with cystic fibrosis (CF) have higher oxidative stress than patients with other diseases or healthy subjects. This results in an increase in reactive oxygen species (ROS) and in a deficit of antioxidant molecules and plays a fundamental role in the progression of chronic lung damage. Although it is known that recurrent infection-inflammation cycles in CF patients generate a highly oxidative environment, numerous clinical and preclinical studies suggest that the airways of a patient with CF present an inherently abnormal proinflammatory milieu due to elevated oxidative stress and abnormal lipid metabolism even before they become infected. This could be directly related to cystic fibrosis transmembrane conductance regulator (CFTR) deficiency, which appears to produce a redox imbalance in epithelial cells and extracellular fluids. This review aims to summarize the main mechanism by which CFTR deficiency is intrinsically responsible for the proinflammatory environment that characterizes the lung of a patient with CF.

Identifiants

pubmed: 36014562
pii: molecules27165324
doi: 10.3390/molecules27165324
pmc: PMC9413234
pii:
doi:

Substances chimiques

CFTR protein, human 0
Reactive Oxygen Species 0
Cystic Fibrosis Transmembrane Conductance Regulator 126880-72-6

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Références

Am J Respir Crit Care Med. 2018 Sep 1;198(5):639-647
pubmed: 29688760
Lancet Respir Med. 2021 Jul;9(7):677-679
pubmed: 33965001
Oxid Med Cell Longev. 2016;2016:8651820
pubmed: 27504149
Int J Mol Sci. 2021 Jun 08;22(12):
pubmed: 34201249
Pediatr Allergy Immunol. 2022 Jan;33 Suppl 27:15-17
pubmed: 35080292
Antioxidants (Basel). 2021 Dec 02;10(12):
pubmed: 34943039
Paediatr Drugs. 2022 Jul;24(4):321-333
pubmed: 35570261
Cells. 2021 Aug 19;10(8):
pubmed: 34440900
J Clin Invest. 2019 May 30;129(8):3448-3463
pubmed: 31145101
J Nutr. 2004 Mar;134(3):489-92
pubmed: 14988435
Biosci Rep. 2022 Jul 29;42(7):
pubmed: 35707985
Front Pharmacol. 2020 Jul 14;11:1059
pubmed: 32760278
Eur Respir J. 2015 Jul;46(1):133-41
pubmed: 25792639
Free Radic Biol Med. 2017 Dec;113:236-243
pubmed: 28982600
Acta Paediatr. 2020 May;109(5):893-899
pubmed: 31899933
Redox Biol. 2020 May;32:101436
pubmed: 32044291
Free Radic Biol Med. 2020 May 20;152:91-99
pubmed: 32142878
J Clin Med. 2019 Nov 06;8(11):
pubmed: 31698802
Pharmaceuticals (Basel). 2022 Feb 11;15(2):
pubmed: 35215328
Int J Biochem Cell Biol. 2014 Jul;52:113-23
pubmed: 24657650
Antioxidants (Basel). 2020 Nov 30;9(12):
pubmed: 33266084
Eurasian J Med. 2017 Jun;49(2):118-123
pubmed: 28638254
Front Physiol. 2021 Feb 04;12:619442
pubmed: 33613309
Exp Ther Med. 2021 Jun;21(6):585
pubmed: 33850557
Hepat Mon. 2013 Aug 14;13(8):e11215
pubmed: 24171010
J Cyst Fibros. 2016 Sep;15(5):583-6
pubmed: 26778616
Front Pharmacol. 2020 Jul 23;11:1096
pubmed: 32848733
Lancet. 2021 Jun 5;397(10290):2195-2211
pubmed: 34090606
J Cyst Fibros. 2019 Nov;18(6):781-789
pubmed: 31031161
BMC Res Notes. 2013 Nov 13;6:461
pubmed: 24225052
Cell Signal. 2021 May;81:109928
pubmed: 33482299
Am J Rhinol Allergy. 2020 Jan;34(1):115-121
pubmed: 31550169
Biochem J. 2021 Oct 29;478(20):3741-3756
pubmed: 34605540
Cochrane Database Syst Rev. 2019 Oct 03;10:CD007020
pubmed: 31580490
J Cyst Fibros. 2015 Mar;14(2):203-10
pubmed: 25458463
J Breath Res. 2018 Feb 20;12(2):026010
pubmed: 29146889

Auteurs

Evelina Moliteo (E)

Pediatric Respiratory Unit, Department of Clinical and Experimental Medicine, San Marco Hospital, University of Catania, Viale Carlo Azeglio Ciampi sn, 95121 Catania, Italy.

Monica Sciacca (M)

Pediatric Respiratory Unit, Department of Clinical and Experimental Medicine, San Marco Hospital, University of Catania, Viale Carlo Azeglio Ciampi sn, 95121 Catania, Italy.

Antonino Palmeri (A)

Pediatric Respiratory Unit, Department of Clinical and Experimental Medicine, San Marco Hospital, University of Catania, Viale Carlo Azeglio Ciampi sn, 95121 Catania, Italy.

Maria Papale (M)

Pediatric Respiratory Unit, Department of Clinical and Experimental Medicine, San Marco Hospital, University of Catania, Viale Carlo Azeglio Ciampi sn, 95121 Catania, Italy.

Sara Manti (S)

Pediatric Respiratory Unit, Department of Clinical and Experimental Medicine, San Marco Hospital, University of Catania, Viale Carlo Azeglio Ciampi sn, 95121 Catania, Italy.
Pediatric Unit, Department of Human and Pediatric Pathology "Gaetano Barresi", AOUP G. Martino, University of Messina, Via Consolare Valeria, 1, 98124 Messina, Italy.

Giuseppe Fabio Parisi (GF)

Pediatric Respiratory Unit, Department of Clinical and Experimental Medicine, San Marco Hospital, University of Catania, Viale Carlo Azeglio Ciampi sn, 95121 Catania, Italy.

Salvatore Leonardi (S)

Pediatric Respiratory Unit, Department of Clinical and Experimental Medicine, San Marco Hospital, University of Catania, Viale Carlo Azeglio Ciampi sn, 95121 Catania, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH